Legal & General Group’s Celldex Therapeutics CLDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.45M | Buy |
71,190
+7,049
| +11% | +$143K | ﹤0.01% | 2101 |
|
|
2025
Q1 | $1.16M | Sell |
64,141
-193
| -0.3% | -$3.5K | ﹤0.01% | 2134 |
|
|
2024
Q4 | $1.63M | Buy |
64,334
+1,353
| +2% | +$34.2K | ﹤0.01% | 2068 |
|
|
2024
Q3 | $2.14M | Buy |
62,981
+4,653
| +8% | +$158K | ﹤0.01% | 1934 |
|
|
2024
Q2 | $2.16M | Buy |
58,328
+1,922
| +3% | +$71.1K | ﹤0.01% | 1919 |
|
|
2024
Q1 | $2.37M | Buy |
56,406
+4,394
| +8% | +$184K | ﹤0.01% | 1870 |
|
|
2023
Q4 | $2.06M | Buy |
52,012
+11,168
| +27% | +$443K | ﹤0.01% | 1944 |
|
|
2023
Q3 | $1.12M | Buy |
40,844
+3,873
| +10% | +$107K | ﹤0.01% | 2148 |
|
|
2023
Q2 | $1.25M | Buy |
36,971
+18,150
| +96% | +$616K | ﹤0.01% | 2120 |
|
|
2023
Q1 | $677K | Buy |
18,821
+1,606
| +9% | +$57.8K | ﹤0.01% | 2245 |
|
|
2022
Q4 | $767K | Buy |
17,215
+360
| +2% | +$16K | ﹤0.01% | 2224 |
|
|
2022
Q3 | $474K | Buy |
16,855
+731
| +5% | +$20.6K | ﹤0.01% | 2361 |
|
|
2022
Q2 | $435K | Sell |
16,124
-652
| -4% | -$17.6K | ﹤0.01% | 2375 |
|
|
2022
Q1 | $572K | Buy |
16,776
+259
| +2% | +$8.83K | ﹤0.01% | 2358 |
|
|
2021
Q4 | $638K | Sell |
16,517
-253
| -2% | -$9.77K | ﹤0.01% | 2342 |
|
|
2021
Q3 | $906K | Buy |
16,770
+10,667
| +175% | +$576K | ﹤0.01% | 2267 |
|
|
2021
Q2 | $204K | Buy |
6,103
+4,402
| +259% | +$147K | ﹤0.01% | 2534 |
|
|
2021
Q1 | $35K | Hold |
1,701
| – | – | ﹤0.01% | 2939 |
|
|
2020
Q4 | $30K | Buy |
+1,701
| New | +$30K | ﹤0.01% | 2951 |
|
|
2018
Q2 | – | Sell |
-1,590
| Closed | -$56K | – | 3358 |
|
|
2018
Q1 | $56K | Sell |
1,590
-712
| -31% | -$25.1K | ﹤0.01% | 2695 |
|
|
2017
Q4 | $99K | Buy |
2,302
+315
| +16% | +$13.5K | ﹤0.01% | 2588 |
|
|
2017
Q3 | $86K | Hold |
1,987
| – | – | ﹤0.01% | 2723 |
|
|
2017
Q2 | $74K | Buy |
1,987
+297
| +18% | +$11.1K | ﹤0.01% | 2762 |
|
|
2017
Q1 | $92K | Sell |
1,690
-530
| -24% | -$28.9K | ﹤0.01% | 2593 |
|
|
2016
Q4 | $118K | Buy |
2,220
+576
| +35% | +$30.6K | ﹤0.01% | 2451 |
|
|
2016
Q3 | $96K | Hold |
1,644
| – | – | ﹤0.01% | 2230 |
|
|
2016
Q2 | $108K | Hold |
1,644
| – | – | ﹤0.01% | 2046 |
|
|
2016
Q1 | $92K | Buy |
1,644
+163
| +11% | +$9.12K | ﹤0.01% | 2107 |
|
|
2015
Q4 | $351K | Buy |
1,481
+266
| +22% | +$63K | ﹤0.01% | 1477 |
|
|
2015
Q3 | $195K | Hold |
1,215
| – | – | ﹤0.01% | 1719 |
|
|
2015
Q2 | $451K | Buy |
1,215
+81
| +7% | +$30.1K | ﹤0.01% | 1356 |
|
|
2015
Q1 | $477K | Buy |
1,134
+213
| +23% | +$89.6K | ﹤0.01% | 1296 |
|
|
2014
Q4 | $258K | Sell |
921
-34
| -4% | -$9.52K | ﹤0.01% | 1454 |
|
|
2014
Q3 | $192K | Buy |
+955
| New | +$192K | ﹤0.01% | 1521 |
|